2026 NPPES data Research Study Specialist NPI 1124154448 M.D.
Verify on CMS →

MARTIN PALMER, M.D.

Research Study Specialist in SEQUIM, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 241 beneficiaries · Research Study Specialist avg: 601
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
80.9739/100
▼ 2 pts below national avg 83.1 · [object Object]
Industry payments
$824.12
11 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARTIN PALMER, M.D. reported a CMS MIPS final score of 80.9739/100 — below the 83.1 national average — and filed 1,119 Medicare Part D claims in 2023.

80.9739/100
MIPS score · -2 vs avg
1K
Part D claims, 2023
84%
generic prescribing
$824.12
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARTIN PALMER, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

81 33rd percentile higher than 33% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about MARTIN PALMER, M.D.?

Near national average

NPI registry status

Active

Issued 02/23/2007

NPI 1124154448

Primary specialty

Research Study Specialist

Rare

472 US NPIs in this specialty

Medicare Part D claims

1,119 86% vs specialty avg

2023 prescription claims

Specialty avg: 601

MIPS final score

80.9739/100 2.126099999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Washington

How Research Study Specialist compares to other specialties among Washington providers

Washington providers

Research Study Specialist share within Washington

1. Research Study Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Research Study Specialist share within Washington

Medicare quality performance — MIPS

MARTIN PALMER, M.D.'s 2023 MIPS final score plotted against the Research Study Specialist national average

Near national average
MIPS Final Score
80.9739/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Research Study Specialist) — 80.9739/100 vs national avg 83.1

0%100%National avg83%81%
MIPS final score (Research Study Specialist) — 80.9739/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARTIN PALMER, M.D. is a Research Study Specialist provider practicing in SEQUIM, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1124154448. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARTIN PALMER, M.D. appears in the CMS NPPES registry as a Research Study Specialist provider holding M.D. credentials at 844 N 5TH AVE, SEQUIM, WA, 98382, with a listed phone of (360) 683-9895. NPI 1124154448 was issued on 02/23/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PALMER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,119 prescription claims written by this provider, covering 241 Medicare beneficiaries and totaling roughly $2.7 million in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 5.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 80.9739/100 for the 2023 performance year (Quality 89.6387, Cost 64.4409), compared with the national average of 83.1.

Research Study Specialist is a narrow specialty nationwide, with 472 enrolled providers across 41 states and an average of 601 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

844 N 5TH AVE
SEQUIM, WA 98382

Provider Details

NPI 1124154448
Specialty Research Study Specialist
Credentials M.D.
Gender Male
NPI Issued 02/23/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

80.9739
Final Score
Avg: 83.1
89.6387
Quality
64.4409
Cost
79
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARTIN PALMER, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

OLYMPIC MEDICAL PHYSICIANS
SEQUIM, WA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARTIN PALMER, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$824

Largest payer

Tempus AI, Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to MARTIN PALMER, M.D.. To verify MARTIN PALMER, M.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARTIN PALMER, M.D. — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 1,119 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,119
Total Claims
$2.7M
Total Drug Cost
241
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,516
Total Day Supply
36,803
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$2.2M
Generic Drug Cost
$542K
Opioid Claims
64 (5.7% rate)
Antibiotic Claims
26

Patient Demographics

Average Patient Age
73.4 years
Avg HCC Risk Score
2.22
Gender Split
53% female / 47% male
Age Distribution
<65: 25, 65-74: 104, 75-84: 85, 85+: 27

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Dexamethasone
97
Prochlorperazine Maleate
64
Olanzapine
60
Abiraterone Acetate
52
Prednisone
52
Tamoxifen Citrate
49
Ondansetron Hcl
48
Hydroxyurea
46
Letrozole
44
Acyclovir
40

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Research Study Specialist Overview

How MARTIN PALMER, M.D. fits within the Research Study Specialist landscape nationally.

472
Research Study Specialist Providers in US
41
States with Research Study Specialist
601
Avg Claims per Provider

MARTIN PALMER, M.D.'s 1,119 claims are above the specialty average of 601.

Nearby Research Study Specialist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as PALMER.

Compare Research Study Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARTIN PALMER, M.D.'s specialty?
MARTIN PALMER, M.D. specializes in Research Study Specialist and practices in SEQUIM, Washington. Credentials: M.D..
How much does MARTIN PALMER, M.D. prescribe under Medicare Part D?
In 2023, MARTIN PALMER, M.D. wrote 1,119 Medicare Part D claims totaling $2.7M in drug costs for 241 beneficiaries.
What is MARTIN PALMER, M.D.'s Medicare quality score?
MARTIN PALMER, M.D. has a CMS MIPS Final Score of 80.9739/100 (Quality: 89.6387, Cost: 64.4409). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARTIN PALMER, M.D. located?
MARTIN PALMER, M.D. is located at 844 N 5TH AVE, SEQUIM, WA, 98382. Phone: (360) 683-9895.
What is MARTIN PALMER, M.D.'s NPI number?
MARTIN PALMER, M.D.'s National Provider Identifier (NPI) is 1124154448, issued on 02/23/2007.
Does MARTIN PALMER, M.D. prescribe more brand-name or generic drugs?
MARTIN PALMER, M.D.'s prescribing is 16% brand-name and 84% generic drugs by claim count, with $2.2M in brand drug costs.
Does MARTIN PALMER, M.D. prescribe opioids?
Yes, MARTIN PALMER, M.D. had 64 opioid claims in 2023 with an opioid prescribing rate of 5.7%.
How many Research Study Specialist providers are there in the US?
There are 472 Research Study Specialist providers across 41 states in the US. The average Research Study Specialist provider writes 601 Medicare Part D claims per year.
What drugs does MARTIN PALMER, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARTIN PALMER, M.D.'s most frequently prescribed drugs include Dexamethasone, Prochlorperazine Maleate, Olanzapine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARTIN PALMER, M.D. accept Medicare?
MARTIN PALMER, M.D. appears in CMS Medicare data with 1,119 Part D claims and 241 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARTIN PALMER, M.D.'s credentials?
MARTIN PALMER, M.D.'s NPI is 1124154448 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology